Integrating multiple lines of evidence to assess the effects of maternal BMI on pregnancy and perinatal outcomes.


Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
29 01 2024
Historique:
received: 29 03 2023
accepted: 09 11 2023
medline: 30 1 2024
pubmed: 29 1 2024
entrez: 28 1 2024
Statut: epublish

Résumé

Higher maternal pre-pregnancy body mass index (BMI) is associated with adverse pregnancy and perinatal outcomes. However, whether these associations are causal remains unclear. We explored the relation of maternal pre-/early-pregnancy BMI with 20 pregnancy and perinatal outcomes by integrating evidence from three different approaches (i.e. multivariable regression, Mendelian randomisation, and paternal negative control analyses), including data from over 400,000 women. All three analytical approaches supported associations of higher maternal BMI with lower odds of maternal anaemia, delivering a small-for-gestational-age baby and initiating breastfeeding, but higher odds of hypertensive disorders of pregnancy, gestational hypertension, preeclampsia, gestational diabetes, pre-labour membrane rupture, induction of labour, caesarean section, large-for-gestational age, high birthweight, low Apgar score at 1 min, and neonatal intensive care unit admission. For example, higher maternal BMI was associated with higher risk of gestational hypertension in multivariable regression (OR = 1.67; 95% CI = 1.63, 1.70 per standard unit in BMI) and Mendelian randomisation (OR = 1.59; 95% CI = 1.38, 1.83), which was not seen for paternal BMI (OR = 1.01; 95% CI = 0.98, 1.04). Findings did not support a relation between maternal BMI and perinatal depression. For other outcomes, evidence was inconclusive due to inconsistencies across the applied approaches or substantial imprecision in effect estimates from Mendelian randomisation. Our findings support a causal role for maternal pre-/early-pregnancy BMI on 14 out of 20 adverse pregnancy and perinatal outcomes. Pre-conception interventions to support women maintaining a healthy BMI may reduce the burden of obstetric and neonatal complications. Medical Research Council, British Heart Foundation, European Research Council, National Institutes of Health, National Institute for Health Research, Research Council of Norway, Wellcome Trust.

Sections du résumé

BACKGROUND
Higher maternal pre-pregnancy body mass index (BMI) is associated with adverse pregnancy and perinatal outcomes. However, whether these associations are causal remains unclear.
METHODS
We explored the relation of maternal pre-/early-pregnancy BMI with 20 pregnancy and perinatal outcomes by integrating evidence from three different approaches (i.e. multivariable regression, Mendelian randomisation, and paternal negative control analyses), including data from over 400,000 women.
RESULTS
All three analytical approaches supported associations of higher maternal BMI with lower odds of maternal anaemia, delivering a small-for-gestational-age baby and initiating breastfeeding, but higher odds of hypertensive disorders of pregnancy, gestational hypertension, preeclampsia, gestational diabetes, pre-labour membrane rupture, induction of labour, caesarean section, large-for-gestational age, high birthweight, low Apgar score at 1 min, and neonatal intensive care unit admission. For example, higher maternal BMI was associated with higher risk of gestational hypertension in multivariable regression (OR = 1.67; 95% CI = 1.63, 1.70 per standard unit in BMI) and Mendelian randomisation (OR = 1.59; 95% CI = 1.38, 1.83), which was not seen for paternal BMI (OR = 1.01; 95% CI = 0.98, 1.04). Findings did not support a relation between maternal BMI and perinatal depression. For other outcomes, evidence was inconclusive due to inconsistencies across the applied approaches or substantial imprecision in effect estimates from Mendelian randomisation.
CONCLUSIONS
Our findings support a causal role for maternal pre-/early-pregnancy BMI on 14 out of 20 adverse pregnancy and perinatal outcomes. Pre-conception interventions to support women maintaining a healthy BMI may reduce the burden of obstetric and neonatal complications.
FUNDING
Medical Research Council, British Heart Foundation, European Research Council, National Institutes of Health, National Institute for Health Research, Research Council of Norway, Wellcome Trust.

Identifiants

pubmed: 38281920
doi: 10.1186/s12916-023-03167-0
pii: 10.1186/s12916-023-03167-0
pmc: PMC10823651
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Subventions

Organisme : Medical Research Council
ID : MC_PC_21038
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : European Research Council
Pays : International
Organisme : NHGRI NIH HHS
ID : U01 HG004415
Pays : United States
Organisme : British Heart Foundation
ID : CH/F/20/90003
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CS/16/4/32482
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK103246
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : R01 HD101669
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

J Clin Epidemiol. 2010 Aug;63(8):932-7
pubmed: 20189760
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
Wellcome Open Res. 2017 Feb 14;2:11
pubmed: 28405635
Acta Paediatr. 2004 Apr;93(4):508-17
pubmed: 15188979
Br J Obstet Gynaecol. 1993 Apr;100(4):310-5
pubmed: 8494831
Int J Epidemiol. 2013 Aug;42(4):978-91
pubmed: 23064411
Transl Psychiatry. 2020 Jan 21;10(1):23
pubmed: 32066667
Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
N Engl J Med. 2008 May 8;358(19):1991-2002
pubmed: 18463375
J Clin Epidemiol. 2020 Feb;118:9-17
pubmed: 31689456
Int J Epidemiol. 2006 Oct;35(5):1146-50
pubmed: 16926217
PLoS One. 2014 Apr 09;9(4):e93766
pubmed: 24718290
J Pediatr. 2012 Jan;160(1):19-24.e4
pubmed: 21885063
Int J Gynaecol Obstet. 2002 Jul;78(1):69-77
pubmed: 12113977
BMJ. 2017 Feb 8;356:j1
pubmed: 28179267
Hum Mol Genet. 2018 Oct 15;27(20):3641-3649
pubmed: 30124842
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
Int J Epidemiol. 2017 Dec 1;46(6):1985-1998
pubmed: 29040600
Nat Genet. 2010 Nov;42(11):937-48
pubmed: 20935630
Nature. 2018 Jan;553(7689):399-401
pubmed: 32094809
Paediatr Perinat Epidemiol. 2006 Mar;20(2):172-9
pubmed: 16466435
Int J Epidemiol. 2016 Jun;45(3):908-15
pubmed: 27427429
Int J Epidemiol. 2016 Dec 1;45(6):1866-1886
pubmed: 28108528
EBioMedicine. 2023 Feb;88:104441
pubmed: 36696816
JAMA Intern Med. 2022 Feb 01;182(2):106-114
pubmed: 34928300
J Obstet Gynaecol Can. 2014 May;36(5):416-41
pubmed: 24927294
Eur J Epidemiol. 2018 Jan;33(1):27-36
pubmed: 29349587
Epidemiology. 2010 May;21(3):383-8
pubmed: 20335814
Nat Genet. 2016 Jul;48(7):817-20
pubmed: 27270105
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Obes Rev. 2008 Nov;9(6):635-83
pubmed: 18673307
Diabetologia. 2021 Dec;64(12):2790-2802
pubmed: 34542646
Acta Paediatr Scand. 1969;193:Suppl 193:1+
pubmed: 4911003
BMC Med. 2022 Feb 1;20(1):34
pubmed: 35101027
Sci Rep. 2020 Mar 16;10(1):4806
pubmed: 32179833
Genet Epidemiol. 2016 Nov;40(7):597-608
pubmed: 27625185
JAMA. 2014 Apr 16;311(15):1536-46
pubmed: 24737366
J Affect Disord. 2021 Feb 15;281:321-330
pubmed: 33341015
PLoS One. 2011;6(9):e24303
pubmed: 21935397
Scand J Public Health. 2001 Dec;29(4):300-7
pubmed: 11775787
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Stat Med. 2011 May 20;30(11):1312-23
pubmed: 21432888
Matern Child Nutr. 2014 Apr;10(2):166-83
pubmed: 22905677
PLoS Med. 2022 Sep 6;19(9):e1004090
pubmed: 36067251
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Int J Epidemiol. 2022 Jan 6;50(6):1786-1787j
pubmed: 34999878
BJOG. 2019 Jul;126(8):984-995
pubmed: 30786138
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
JAMA. 2021 May 25;325(20):2094-2109
pubmed: 34032824
BMJ. 2017 Jul 19;358:j3119
pubmed: 28724518
Eur J Epidemiol. 2016 Dec;31(12):1243-1264
pubmed: 28070760
Nat Genet. 2009 Jan;41(1):35-46
pubmed: 19060910
Nat Genet. 2019 May;51(5):804-814
pubmed: 31043758
JAMA. 2016 Mar 15;315(11):1129-40
pubmed: 26978208
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Obes Rev. 2015 Jul;16(7):531-46
pubmed: 25912896
Int J Epidemiol. 2016 Apr;45(2):382-8
pubmed: 27063603
Genet Epidemiol. 2010 Sep;34(6):591-602
pubmed: 20718045
PLoS Med. 2019 Nov 13;16(11):e1002972
pubmed: 31721775
Int J Epidemiol. 2018 Apr 1;47(2):587-596
pubmed: 29088358
BMJ Open. 2016 Feb 03;6(2):e010031
pubmed: 26842272
Int J Epidemiol. 2019 Jun 1;48(3):861-875
pubmed: 30815700
J Affect Disord. 2016 Sep 15;202:124-7
pubmed: 27262633
Obes Rev. 2015 Aug;16(8):621-38
pubmed: 26016557
PLoS Med. 2007 Dec;4(12):e352
pubmed: 18076282
J Obstet Gynaecol Can. 2016 Aug;38(8):703-11
pubmed: 27638980
Hum Genet. 2008 Feb;123(1):15-33
pubmed: 18038153
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Bioinformatics. 2010 Nov 15;26(22):2867-73
pubmed: 20926424
PLoS One. 2009 Dec 24;4(12):e8444
pubmed: 20041193
Front Nutr. 2022 Feb 17;9:789833
pubmed: 35252291
Int J Epidemiol. 2012 Aug;41(4):930-40
pubmed: 21471022
Obstet Gynecol. 2014 Apr;123(4):857-67
pubmed: 24785615
Hum Mol Genet. 2022 Sep 29;31(19):3377-3391
pubmed: 35220425
Nat Rev Methods Primers. 2022 Feb 10;2:
pubmed: 37325194
J Midwifery Womens Health. 2019 Jan;64(1):55-67
pubmed: 30648804
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Obes Rev. 2009 Jan;10(1):28-35
pubmed: 19021871
Metabolites. 2022 Jun 10;12(6):
pubmed: 35736469

Auteurs

Maria Carolina Borges (MC)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK. m.c.borges@bristol.ac.uk.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK. m.c.borges@bristol.ac.uk.

Gemma L Clayton (GL)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.

Rachel M Freathy (RM)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK.

Janine F Felix (JF)

The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Alba Fernández-Sanlés (A)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.

Ana Gonçalves Soares (AG)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.

Fanny Kilpi (F)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.

Qian Yang (Q)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.

Rosemary R C McEachan (RRC)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Trust, Bradford, UK.

Rebecca C Richmond (RC)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.

Xueping Liu (X)

Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

Line Skotte (L)

Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

Amaia Irizar (A)

Department of Preventive Medicine and Public Health, University of the Basque Country, Leioa, Spain.
BIODONOSTIA Health Research Institute, Paseo Dr. Beguiristain, 20014, San Sebastian, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Andrew T Hattersley (AT)

Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK.

Barbara Bodinier (B)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.

Denise M Scholtens (DM)

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Ellen A Nohr (EA)

Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.

Tom A Bond (TA)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.
Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Australia.

M Geoffrey Hayes (MG)

Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Jane West (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Trust, Bradford, UK.

Jessica Tyrrell (J)

Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK.

John Wright (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Trust, Bradford, UK.

Luigi Bouchard (L)

Department of Biochemistry and Functional Genomics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada.

Mario Murcia (M)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, Valencia, Spain.

Mariona Bustamante (M)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
ISGlobal, Institute for Global Health, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Marc Chadeau-Hyam (M)

Faculty of Medicine, School of Public Health, Imperial College London, London, UK.

Marjo-Riitta Jarvelin (MR)

Faculty of Medicine, School of Public Health, Imperial College London, London, UK.

Martine Vrijheid (M)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
ISGlobal, Institute for Global Health, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Patrice Perron (P)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CR-CHUS), Sherbrooke, Québec, Canada.
Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Québec, Canada.

Per Magnus (P)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Romy Gaillard (R)

The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Vincent W V Jaddoe (VWV)

The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

William L Lowe (WL)

Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Bjarke Feenstra (B)

Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

Marie-France Hivert (MF)

Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.

Thorkild I A Sørensen (TIA)

Department of Public Health, Section of Epidemiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Novo Nordisk Foundation Center for Basic Metabolic Diseases, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Siri E Håberg (SE)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Sylvain Serbert (S)

Center For Life-Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.

Maria Magnus (M)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Deborah A Lawlor (DA)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK. d.a.lawlor@bristol.ac.uk.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK. d.a.lawlor@bristol.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH